摘要
目的:探讨卡孕栓预防产后出血的临床效果。方法:2013年4月-2014年4月收治产妇100例,按照治疗方式不同分为对照组与研究组,对照组给予缩宫素肌注,研究组给予卡孕栓舌下含服,观察两组产妇发生产后出血的情况,并记录产后2 h及24 h内的出血量及不良反应。结果:比较两组产妇发生产后出血的比例、第三产程时间、产后2 h出血量、产后24 h出血量、产后血红蛋白指数,差异有统计学意义(P<0.05)。仅研究组出现1例腹泻,无其他不良反应,差异无统计学意义(P>0.05)。结论:卡孕栓能有效缩短产妇的第三产程,同时降低产妇产后出血的几率,减少产后出血量,并无其他严重不良反应,具有较高的临床推广价值。
Objective:To explore the curative effect of carboprost in prevention of postpartum hemorrhage.Methods:100 pregnant women were selected from April 2013 to April 2014.According to the different treatment,they were divided into the control group and the study group.The control group was given oxytocin intramuscular injection,and the study group was given sublingual administration of carboprost.We observed the postpartum hemorrhage of the two groups,recorded postpartum 2 hours and 24 hours hemorrhage volume and adverse reactions.Results:We compared the proportion of third postpartum hemorrhage,the third stage of labor time,2 hours postpartum hemorrhage volume,24 hours postpartum hemorrhage volume,postpartum hemoglobin index,and the difference was statistically significant(P<0.05).In the study group,1 case had diarrhea,there was no other adverse reactions,and there was no significant difference(P>0.05).Conclusion:Carboprost can effectively reduce maternal third birth process,at the same time,it can reduce the risk of postpartum hemorrhage,reduce the amount of postpartum hemorrhage,and there was no other serious adverse reactions,so it had high clinical value.
出处
《中国社区医师》
2015年第12期71-71,73,共2页
Chinese Community Doctors
关键词
卡孕栓
缩宫素
产后出血
Carboprost
Oxytocin
Postpartum hemorrhage